Kingston Clinical Commissioning Group Governing Body Meeting in Public Date Tuesday, 08 January 2019 Document Title Dementia Deep Dive Lead Director Julia Travers (Name and Role) Director of Commissioning Clinical Sponsor Dr Phil Moore (Name and Role) Chair (Clinical) Author(s) Brian Roberts, Performance and Information Lead (Name and Role) Rachel Rowan, Mental Health Commissioner Dr Nerida Burnie, Dementia Lead and Kingston GP Agenda Item No. 2.1 Attachment No. C Purpose Note Discuss Approve (Tick as Required) Executive Summary CCGs are expected to encourage timely diagnosis of patients with dementia. To this end, the dementia diagnosis standard was introduced, and is monitored by NHS England. The measure calculates the dementia diagnosis rate by using the number of people aged 65 and over with a diagnosis of dementia recorded within GP practice systems, over the estimated number of people aged 65 and over expected to have dementia in the population. Background: At present, the diagnosis rate in Kingston is 62.2% against an expected rate of 66.7% (equates to 80 people short of the expected rate). There have been several actions carried out by the CCG in support of GPs to increase the number and rate of people diagnosed with dementia, with other actions still being currently carried out. Further information will be covered in the presentation to the governing body meeting. Purpose: To inform the Kingston CCG Governing Body of the performance of the dementia standard against the targeted level. Reason for Committee Review: To make the Kingston CCG Governing Body aware of the actions that have been carried out and the ongoing actions that are still being currently carried out. Key Issues: 1. At present, the diagnosis rate in Kingston is 62.2%, 80 people short of the expected rate. Kingston CCG is in the minority of CCGs that are not achieving the standard. Page 1 of 3
2. The rate of nursing home beds and the proportions of people that are expected to have dementia are not outliers within Kingston, compared to South West London and the England average. 3. Kingston CCG meets with NHS England regularly for support to increase the proportion of people diagnosed with dementia. Conflicts of Interest: None Mitigations: None Recommendation: The Committee is asked to consider the report Corporate Objectives Improve the quality, safety and effectiveness of healthcare This document will impact on services and ensure that national performance targets are the following CCG Objectives: met and that people experience high quality care Risks There is a risk of failing to meet some of the national This document links to the performance targets, based on previous performance following CCG risks: Mitigations The performance monitored monthly, and is reported to the Actions taken to reduce any Kingston CCG Integrated Governance Committee and to risks identified: the Governing Body Financial/Resource/ There may be a financial implication relating to some QIPP Implications recovery actions. Has an Equality Impact N/A Assessment (EIA) been completed? Are there any known N/A implications for equalities? If so, what are the mitigations? Patient and Public N/A Engagement and Communication Page 2 of 3
Previous Committee/Group Name: Date Outcome: Committees/ Discussed: Groups Integrated Governance Tuesday, 16 The Report was noted. Enter any Committee October 2018 Committees/ Integrated Governance Tuesday, 18 The Report was noted. Groups at which Committee December this document has 2018 been previously considered: Click here to enter a date. Supporting Documents Presentation attached . Page 3 of 3
Recommend
More recommend
